In sum, the above results showed that LH is worthy being further researched as a clinical drug for gastric cancer treatment, and these findings provided a theoretical basis for the development of clinical drugs targeting MCL1 in gastric cancer. This evidence concerns the gene PLOD1 and gastric cancer.